短期培训,在坦桑尼亚,肯尼亚,埃塞俄比亚和卢旺达可持续药监知识发展的有用方法
Eugène van Puijenbroek1,2, Abbie Barry3, Christabel Khaemba4
1University of Groningen, Groningen Research Institute of Pharmacy, Pharmacotherapy, Epidemiology and Economics, Groningen, The Netherlands. e.p.van.puijenbroek@rug.nl.
Drug safety
|August 20, 2024
概括
短期培训 (STT) 增强了东非的药监系统. 这项能力建设计划改善了埃塞俄比亚,肯尼亚,卢旺达和坦桑尼亚的药物安全监测和监管协调.
科学领域:
- 药监和药物安全 药监和药物安全
- 监管科学 监管科学
- 公共卫生能力建设
背景情况:
- 持续的专业发展对于有效的药监系统至关重要.
- 加强国家光伏基础设施和营销后监管对于区域协调至关重要.
研究的目的:
- 描述开发和实施短期培训 (STT) 以提高东非的光伏产能.
- 评估STT对埃塞俄比亚,肯尼亚,卢旺达和坦桑尼亚光伏知识转移和技能发展的影响.
主要方法:
- 在国家药品监管机构 (NMRA) 和医学大学进行了PV教学和实践的基线评估.
- 提供了五个定制的STT会议,包括基本的PV概念和培训员课程.
- 跨国参与培训促进了合作和学习.
主要成果:
- STT活动是根据国家特定的需求和监管环境量身定制的.
- 从NMRA和医学大学内的光伏部门培训目标人员.
- 参与国家观察到知识转移和技能发展,加强大学教育和NMRA运营.
结论:
- 对STT的战略投资以及与学术机构和NMRA的合作伙伴关系为增强光伏能力提供了一种可持续的方法.
- PROFORMA项目模型显示了在非洲各地复制的潜力,以改善药物安全监管.
- 增强的光伏系统通过改善药物安全监测,有助于更好地保护公共卫生.
更多相关视频
相关概念视频
Pharmacovigilance
797
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
797
Analysis of Population Pharmacokinetic Data
241
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
241
Pulmonary Tuberculosis V
174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174
Principles of Disease Surveillance
81
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
81
International Nursing Organizations II
975
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
975
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K


